Premium
Efficacy of Structurally Diverse Aldose Reductase Inhibitors on Experimental Periodontitis in Rats
Author(s) -
Kador Peter F.,
O'Meara James D.,
Blessing Karen,
Marx David B.,
Reinhardt Richard A.
Publication year - 2011
Publication title -
journal of periodontology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.036
H-Index - 156
eISSN - 1943-3670
pISSN - 0022-3492
DOI - 10.1902/jop.2010.100442
Subject(s) - periodontitis , aldose reductase , dental alveolus , diabetes mellitus , porphyromonas gingivalis , sorbitol , medicine , endocrinology , streptozotocin , crown lengthening , dentistry , chemistry , biochemistry , crown (dentistry)
Background: To study aldose reductase and the sorbitol pathway in periodontitis and diabetes, rats with experimental periodontitis with or without diabetes were treated with three structurally diverse aldose reductase inhibitors (ARIs). Methods: Periodontitis was induced with three consecutive palatal injections of Porphyromonas gingivalis lipopolysaccharide (LPS) at 48‐hour intervals between the first and second molars on the right side in young, age‐matched, streptozotocin‐induced rats with and without diabetes 44 days after initiation of diets with and without the ARIs tolrestat, imirestat, and quercetin. As an internal control, phosphate‐buffered saline (PBS) was similarly injected on the left side. Twenty‐four days after the final injection, all rats were euthanized. Defleshed samples were stained with 5% toluidine blue and palatal digital images were traced to include the enamel crown and exposed root. The root/enamel ratios (to estimate alveolar bone loss) were analyzed with repeated measures analysis of variance. Results: LPS injections resulted in significantly more bone loss versus PBS injections in both the rats with and without diabetes on normal diets ( P <0.0001). All three ARIs significantly reduced LPS‐induced periodontitis in the animals with and without diabetes ( P ≤0.003) to the level where they were not different from PBS‐injected sites in normal diet controls. Conclusion: All ARIs demonstrated efficacy in preventing alveolar bone loss because of periodontitis in both animals with and without diabetes, suggesting a role for the sorbitol pathway and the potential for ARIs to reduce inflammatory responses downstream from aldose reductase.